2,200
Participants
Start Date
February 1, 2025
Primary Completion Date
July 7, 2028
Study Completion Date
January 7, 2030
Contrast Enhancement Mammography
In the experimental arm women will receive two rounds of CEM surveillance. After 2 years, all women who were randomly assigned to receive either MRI or CEM will undergo the same exit test. This exit test is the standard test used for the surveillance of high-risk non mutated women at each participating center.
magnetic resonance imaging (MRI) and digital mammography (DM)
women will receive two rounds of MRI+DM surveillance. After 2 years, all women who were randomly assigned to receive either MRI or CEM will undergo the same exit test. This exit test is the standard test used for the surveillance of high-risk nonmutated women at each participating center.
RECRUITING
Istituto in tecnologie avanzate e modelli assistenziali in oncologia - AUSL-IRCCS Reggio Emilia, Reggio Emilia
Istituto Oncologico Veneto I.O.V. - I.R.C.C.S.
UNKNOWN
"Azienda Ospedaliera Universitaria Policlinico G. Martino"
OTHER
Azienda Ospedaliera Universitaria (AOU) Bari
UNKNOWN
Azienda Ospedaliera Universitaria Integrata Verona
OTHER
Fondazione IRCCS Policlinico San Matteo di Pavia
OTHER
Azienda Ospedaliero-Universitaria di Modena
OTHER
Azienda USL della Romagna
UNKNOWN
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
OTHER
Azienda USL Reggio Emilia - IRCCS
OTHER_GOV